Spark Therapeutics (ONCE) Prices 7M Common IPO at $23/Share, Above Expected Range
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
Spark Therapeutics (ONCE) Sees Early Selling After Friday's Hot IPO
February 2, 2015 9:33 AM ESTFriday's hot IPO for Spark Therapeutics (NASDAQ: ONCE) is seeing profit taking after Friday's 117% gain. Shares last traded down 4.8% to $47.60.
Spark Therapeutics (ONCE) IPO Opens Up 96%
January 30, 2015 11:18 AM ESTToday's IPO for Spark Therapeutics (NASDAQ: ONCE) opened for trading at $45.10 after pricing 7,000,000 shares of common stock at a public offering price of $23.00 per share, above the expected $19-$21 range.
J.P. Morgan Securities LLC and Credit Suisse Securities (USA) LLC are acting... More
Spark Therapeutics (ONCE) Boosts Expected IPO Price Range
January 28, 2015 6:24 AM ESTSpark Therapeutics (NASDAQ: ONCE) filed an amended registration with the U.S. SEC for an IPO of its common stock. The company plans to sell 6.5 million shares and sees an offering price of $19 - $21 per share, from a prior range of $15 - $17... More
